{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:48:22Z","timestamp":1791244102606,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) is the second leading cause of death globally. Furthermore, HCC patients have poor long-term survival following curative resection because of a high rate of tumor recurrence. Little is known about the genomic trajectory from primary to early recurrent HCC. The HCC patient survival rate has improved because of improved diagnostic protocols. Increasing numbers of lncRNAs have been revealed to be involved in the carcinogenesis and progression of HCC. Among them, The aim of our study was to examine the prognostic value of Loxl1-As1 expression in patients with HCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this study, we analyzed Loxl1-As1 expression in HCC using tissue microarray and fluorescence <jats:italic toggle=\"yes\">in situ<\/jats:italic> hybridization. The expression of lncRNA Downregulated in metastatic HCC (Loxl1-As1) in cell lines and tissues was detected by quantitative real-time polymerase chain reaction and <jats:italic toggle=\"yes\">in situ<\/jats:italic> hybridization (ISH); cell counting kit-8, colony formation, and flow cytometry were performed to investigate the role of Loxl1-As1 in HCC cell proliferation, cell cycle progression, and apoptosis <jats:italic toggle=\"yes\">in vitro<\/jats:italic>; migration was investigated in HCC cell lines <jats:italic toggle=\"yes\">in vitro<\/jats:italic>; and Western blot was used to detect the downstream of Loxl1-As1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Clinically, Loxl1-As1 correlated with poor prognosis of HCC. Loxl1-As1 was downregulated in HCC tissues and cell lines. The ISH assay revealed that Loxl1-As1 expression was significantly decreased in 177 paraffin-embedded samples from patients with HCC compared with non-tumor tissues and Loxl1-As1 expression directly correlated with patient prognosis. <jats:italic toggle=\"yes\">In vitro<\/jats:italic> studies indicated that Loxl1-As1 promoted the proliferation and clonogenicity of HCC cells and the expression of Loxl1-As1 suppressed the growth, migration, and metastasis of HCC cells <jats:italic toggle=\"yes\">in vitro.<\/jats:italic>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Collectively, the findings demonstrate that Loxl1-As1 is over-expressed in HCC patients and associated with a poor prognosis. Additionally, Loxl1-As1 plays an important role in HCC progression. These findings support the notion that lncRNA Loxl1-As1 might be a new driver biomarker and future therapeutic target for HCC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003448","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:00:35Z","timestamp":1748502035000},"page":"4811-4820","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Long noncoding RNA Loxl1-As1 promotes cell apoptosis and suppresses cell proliferation in hepatocellular carcinoma in vitro"],"prefix":"10.1097","volume":"87","author":[{"given":"Maher","family":"Hendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-0760","authenticated-orcid":false,"given":"Xiu-jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.29258","article-title":"The past, present, and future of cancer incidence in the United States: 1975 through 2020","volume":"121","author":"Hannah","year":"2015","journal-title":"Cancer"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"C\u00e9cile","year":"2012","journal-title":"Nat Genet"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijrobp.2020.07.033","article-title":"A pilot trial evaluating stereotactic body radiation therapy to induce hyperemia in combination with transarterial chemoembolization for hepatocellular carcinoma","volume":"108","author":"Nikhil","year":"2020","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1002\/ctm2.137","article-title":"Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: a single-center, retrospective, propensity matched study","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Transl Med"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.stem.2015.02.002","article-title":"Long non-coding RNAs control hematopoietic stem cell function","volume":"16","author":"Min","year":"2015","journal-title":"Cell Stem Cell"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Matthew","year":"2015","journal-title":"Nat Genet"},{"key":"R7-20250806","first-page":"6091","article-title":"LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT\/mTOR signaling pathways","author":"Li","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"122e129","DOI":"10.1016\/j.lfs.2018.02.006","article-title":"LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells","volume":"197","author":"Li","year":"2018","journal-title":"Life Sci"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1138341","article-title":"RNA maps reveal new RNA classes and a possible function for pervasive transcription","volume":"316","author":"Philipp","year":"2007","journal-title":"Science"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2018.09.160","article-title":"Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1","volume":"505","author":"Long","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ygeno.2019.06.017","article-title":"lncRNA SNHG16 promotes glioma tumorigenicity through miR-373\/EGFR axis by activating PI3K\/AKT pathway","volume":"112","author":"Zhou","year":"2020","journal-title":"Genomics"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2019.04.089","article-title":"Longnon-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"e12687","DOI":"10.1111\/cpr.12687","article-title":"lncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p\/USF1 pathway","volume":"52","author":"Sun","year":"2019","journal-title":"Cell Prolif"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-15-2461","article-title":"Lysyl oxidase (LOX) transcriptionally regulates SNAI2 expression and TIMP4 secretion in human cancers","volume":"22","author":"Boufraqech","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-16-1676","article-title":"Emerging role of microRNAs as liquid biopsy biomarkers ingastrointestinal cancers","volume":"23","author":"Shigeyasu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"152435","DOI":"10.1016\/j.prp.2019.152435","article-title":"Long non-coding RNAs in retinoblastoma","volume":"215","author":"Yang","year":"2019","journal-title":"Pathol Res Pract"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol Rev"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"BSR20190447","DOI":"10.1042\/BSR20190447","article-title":"LOXL1-AS1 predicts poor prognosis and promotes cell proliferation,migration, and invasion in osteosarcoma","volume":"39","author":"Chen","journal-title":"Biosci Rep"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"9275685","DOI":"10.1155\/2018\/9275685","article-title":"LncRNA LOXL1-AS1 promotes the proliferation and metastasis of medulloblastoma by activating the PI3K\/AKT pathway","volume":"2018","author":"Gao","year":"2018","journal-title":"Anal Cell Pathol"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2018.04.133","article-title":"Silencing lncRNA LOXL1-AS1 attenuates mesenchymal charac-teristics of glioblastoma via NF-\u03baB pathway","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.2147\/OTT.S223702","article-title":"LOXL1-AS1 drives the progression of gastric cancer via regulating miR-142-5p\/PIK3CAAxis","volume":"20","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.omtn.2019.12.016","article-title":"Long non-coding RNA LOXL1-AS1 drives breast cancer invasion and metastasis by antagonizing miR-708-5p expression and activity","volume":"19","author":"Dong","year":"2020","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:15:07Z","timestamp":1754496907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003448","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"2025-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}